As expected, insulin treatment in this model had beneficial effects on glucose control and dyslipidemia and increased body weight and fat mass, but also significantly improved liver histopathology by decreasing hepatic steatosis, inflammation and stellate cell activation. Here, INS is linked to Hepatic steatosis.